Cancel
Lupin
See Linkedin
Lupin Employees
9 people indexed:
-
x8q0rkrkb8k79w@jxvx8.h88 Sign up to see email
-
zsfy2b27kg@tbf41.xsy Sign up to see email
-
vvv0vvs9xgg901@z4q2b.z68 Sign up to see email
-
1zfxx4.vz68q@z221s.w88 Sign up to see email
-
x2r152x.682vz@z0zfz.y7q Sign up to see email
-
2f11k1b96f998q1yq@6bky9.8xv Sign up to see email
-
12qf2dv7@w9dkz.3aj Sign up to see email
-
0qrbqqwb0yr@y4j4f.993 Sign up to see email
-
wq20eeb8ykz@0ssk3.79s Sign up to see email
Lupin Company Information
Lupin is a global pharmaceutical company that operates in over 100 countries and employs more than 20,000 people. The company runs 15 state-of-the-art manufacturing facilities across India, the US, Brazil, and Mexico. Lupin offers a wide range of products, including branded and generic formulations, biotech products, Active Pharmaceutical Ingredients (API), and specialty drugs. It is a global leader in the Anti-Tuberculosis segment and provides products in key therapeutic areas such as diabetes, cardiology, respiratory, and ophthalmology. Additionally, Lupin offers over-the-counter products through divisions like LupinLife Consumer Care in India and Pharmacy Action in Australia. The company engages in corporate social responsibility activities that impact 2.5 million lives across nine states. During the COVID-19 pandemic, Lupin participated in global relief efforts by providing monetary and material support, launching Covihalt (Favipiravir) in India for COVID-19 treatment, and Albuterol in the US, a key rescue inhalation product. Lupin also contributed to the PM CARES Fund and other initiatives to support COVID-19 relief efforts.
Report inaccurate information
Report inaccurate information
